Trials / Unknown
UnknownNCT00715286
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study
Neoadjuvant Chemotherapy (NACT) Followed by Interval Debulking Surgery vs Upfront Surgery Followed by Chemotherapy (CT) in Advanced Epithelial Ovarian Carcinoma (EOC): A Prospective Randomized Study
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- All India Institute of Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To determine the impact of Neoadjuvant chemotherapy on surgical debulking rate, overall and disease-free survival and quality of life (QOL) in patients with advanced EOC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | timing of surgery | Surgery is followed by chemotherapy |
| OTHER | timing of surgery | Chemotherapy is followed by surgery |
Timeline
- Start date
- 2001-11-01
- Primary completion
- 2007-04-01
- Completion
- 2009-06-01
- First posted
- 2008-07-15
- Last updated
- 2008-07-15
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT00715286. Inclusion in this directory is not an endorsement.